FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035005482> ?p ?o ?g. }

• W3035005482 endingPage "1152" @default.
• W3035005482 startingPage "1147" @default.
• W3035005482 abstract "Abstract Patients with refractory angina who are suboptimal candidates for further revascularization have improved exercise time, decreased angina frequency, and reduced major adverse cardiac events with intramyocardial delivery of CD34+ cells. However, the effect of CD34+ cell therapy on health care expenditures before and after treatment is unknown. We determined the effect of CD34+ cell therapy on cardiac-related hospital visits and costs during the 12 months following stem cell injection compared with the 12 months prior to injection. Cardiac-related hospital admissions and procedures were retrospectively tabulated for patients enrolled at one site in one of three double-blinded, placebo-controlled CD34+ trials in the 12 months before and after intramyocardial injections of CD34+ cells vs placebo. Fifty-six patients were randomized to CD34+ cell therapy (n = 37) vs placebo (n = 19). Patients randomized to cell therapy experienced 1.57 ± 1.39 cardiac-related hospital visits 12 months before injection, compared with 0.78 ± 1.90 hospital visits 12 months after injection, which was associated with a 62% cost reduction translating to an average savings of $5500 per cell therapy patient. Patients in the placebo group also demonstrated a reduction in cardiac-related hospital events and costs, although to a lesser degree than the CD34+ group. Through 1 January 2019, 24% of CD34+ subjects died at an average of 6.5 ± 2.4 years after enrollment, whereas 47% of placebo patients died at an average of 3.7 ± 1.9 years after enrollment. In conclusion, CD34+ cell therapy for subjects with refractory angina is associated with improved mortality and a reduction in hospital visits and expenditures for cardiac procedures in the year following treatment." @default.
• W3035005482 created "2020-06-19" @default.
• W3035005482 creator A5007480001 @default.
• W3035005482 creator A5010240121 @default.
• W3035005482 creator A5031305752 @default.
• W3035005482 creator A5043447056 @default.
• W3035005482 creator A5048826863 @default.
• W3035005482 creator A5057994256 @default.
• W3035005482 creator A5059617617 @default.
• W3035005482 creator A5068385320 @default.
• W3035005482 date "2020-06-12" @default.
• W3035005482 modified "2023-10-16" @default.
• W3035005482 title "CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina" @default.
• W3035005482 cites W1569560733 @default.
• W3035005482 cites W1770364220 @default.
• W3035005482 cites W1964774705 @default.
• W3035005482 cites W1988592291 @default.
• W3035005482 cites W2046253273 @default.
• W3035005482 cites W2097401006 @default.
• W3035005482 cites W2106015219 @default.
• W3035005482 cites W2111004371 @default.
• W3035005482 cites W2115260446 @default.
• W3035005482 cites W2129396577 @default.
• W3035005482 cites W2130999104 @default.
• W3035005482 cites W2140165420 @default.
• W3035005482 cites W2159376400 @default.
• W3035005482 cites W2207565612 @default.
• W3035005482 cites W2508655590 @default.
• W3035005482 cites W2781806513 @default.
• W3035005482 cites W2886898998 @default.
• W3035005482 cites W2913705661 @default.
• W3035005482 cites W2981029611 @default.
• W3035005482 cites W2998125074 @default.
• W3035005482 doi "https://doi.org/10.1002/sctm.20-0046" @default.
• W3035005482 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7519768" @default.
• W3035005482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32531108" @default.
• W3035005482 hasPublicationYear "2020" @default.
• W3035005482 type Work @default.
• W3035005482 sameAs 3035005482 @default.
• W3035005482 citedByCount "14" @default.
• W3035005482 countsByYear W30350054822021 @default.
• W3035005482 countsByYear W30350054822022 @default.
• W3035005482 countsByYear W30350054822023 @default.
• W3035005482 crossrefType "journal-article" @default.
• W3035005482 hasAuthorship W3035005482A5007480001 @default.
• W3035005482 hasAuthorship W3035005482A5010240121 @default.
• W3035005482 hasAuthorship W3035005482A5031305752 @default.
• W3035005482 hasAuthorship W3035005482A5043447056 @default.
• W3035005482 hasAuthorship W3035005482A5048826863 @default.
• W3035005482 hasAuthorship W3035005482A5057994256 @default.
• W3035005482 hasAuthorship W3035005482A5059617617 @default.
• W3035005482 hasAuthorship W3035005482A5068385320 @default.
• W3035005482 hasBestOaLocation W30350054821 @default.
• W3035005482 hasConcept C10205521 @default.
• W3035005482 hasConcept C121332964 @default.
• W3035005482 hasConcept C126322002 @default.
• W3035005482 hasConcept C141071460 @default.
• W3035005482 hasConcept C142424586 @default.
• W3035005482 hasConcept C142724271 @default.
• W3035005482 hasConcept C164705383 @default.
• W3035005482 hasConcept C168563851 @default.
• W3035005482 hasConcept C197934379 @default.
• W3035005482 hasConcept C204787440 @default.
• W3035005482 hasConcept C27081682 @default.
• W3035005482 hasConcept C2777785093 @default.
• W3035005482 hasConcept C2778425758 @default.
• W3035005482 hasConcept C28328180 @default.
• W3035005482 hasConcept C42219234 @default.
• W3035005482 hasConcept C500558357 @default.
• W3035005482 hasConcept C54355233 @default.
• W3035005482 hasConcept C71924100 @default.
• W3035005482 hasConcept C86803240 @default.
• W3035005482 hasConcept C87355193 @default.
• W3035005482 hasConceptScore W3035005482C10205521 @default.
• W3035005482 hasConceptScore W3035005482C121332964 @default.
• W3035005482 hasConceptScore W3035005482C126322002 @default.
• W3035005482 hasConceptScore W3035005482C141071460 @default.
• W3035005482 hasConceptScore W3035005482C142424586 @default.
• W3035005482 hasConceptScore W3035005482C142724271 @default.
• W3035005482 hasConceptScore W3035005482C164705383 @default.
• W3035005482 hasConceptScore W3035005482C168563851 @default.
• W3035005482 hasConceptScore W3035005482C197934379 @default.
• W3035005482 hasConceptScore W3035005482C204787440 @default.
• W3035005482 hasConceptScore W3035005482C27081682 @default.
• W3035005482 hasConceptScore W3035005482C2777785093 @default.
• W3035005482 hasConceptScore W3035005482C2778425758 @default.
• W3035005482 hasConceptScore W3035005482C28328180 @default.
• W3035005482 hasConceptScore W3035005482C42219234 @default.
• W3035005482 hasConceptScore W3035005482C500558357 @default.
• W3035005482 hasConceptScore W3035005482C54355233 @default.
• W3035005482 hasConceptScore W3035005482C71924100 @default.
• W3035005482 hasConceptScore W3035005482C86803240 @default.
• W3035005482 hasConceptScore W3035005482C87355193 @default.
• W3035005482 hasFunder F4320310310 @default.
• W3035005482 hasIssue "10" @default.
• W3035005482 hasLocation W30350054821 @default.
• W3035005482 hasLocation W30350054822 @default.
• W3035005482 hasOpenAccess W3035005482 @default.

• next